Selected article for: "acute ali lung injury and lung injury"

Author: Lu, Yan; Jiang, Yun; Ling, Lijun; Zhang, Yunyi; Li, Hong; Chen, Daofeng
Title: Beneficial effects of Houttuynia cordata polysaccharides on “two-hit” acute lung injury and endotoxic fever in rats associated with anti-complementary activities
  • Document date: 2017_12_8
  • ID: q4r36tpw_2
    Snippet: Acute lung injury (ALI) is characterized with respiratory dysfunction, hypoxemia with presence of diffuse pulmonary infiltrates, widespread lung inflammation 7 , increased pulmonary vascular permeability and accumulation of activated neutrophils in the lung 8 . Acute respiratory distress syndrome (ARDS) is the most severe form of ALI 9 . Complement activation is an early step in ALI 3 through both the classical pathway and the alternative pathway.....
    Document: Acute lung injury (ALI) is characterized with respiratory dysfunction, hypoxemia with presence of diffuse pulmonary infiltrates, widespread lung inflammation 7 , increased pulmonary vascular permeability and accumulation of activated neutrophils in the lung 8 . Acute respiratory distress syndrome (ARDS) is the most severe form of ALI 9 . Complement activation is an early step in ALI 3 through both the classical pathway and the alternative pathway 10 . The loss of endothelial integrity in the process of ALI/ARDS also causes injured pulmonary cells to release some tissue factors or enzymes, which would lead to the initiation of complement cascade 10, 11 . A cycle of complement activation and lung injury is consequently formed. Hence, the application of complement inhibitors should be a novel treatment strategy for infectious fever and ALI.

    Search related documents:
    Co phrase search for related documents
    • activate neutrophil and acute lung injury: 1
    • activate neutrophil and ARDS respiratory distress syndrome: 1
    • activate neutrophil and distress syndrome: 1
    • acute ARDS respiratory distress syndrome and ALI acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ARDS respiratory distress syndrome and ALI ARDS process: 1
    • acute ARDS respiratory distress syndrome and ARDS respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ARDS respiratory distress syndrome and complement activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute ARDS respiratory distress syndrome and complement inhibitor: 1
    • acute ARDS respiratory distress syndrome and distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute ARDS respiratory distress syndrome and endothelial integrity: 1, 2, 3, 4, 5, 6
    • acute lung injury and ALI acute lung injury: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and ALI ARDS process: 1
    • acute lung injury and ARDS respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and complement activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • acute lung injury and complement inhibitor: 1, 2, 3
    • acute lung injury and distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute lung injury and endothelial integrity: 1, 2, 3, 4, 5, 6, 7, 8
    • ALI acute lung injury and ARDS respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • ALI acute lung injury and complement activation: 1, 2, 3, 4, 5, 6